Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Working Groups Hot Topics

Image Added


PHUSE collaborations are organised into a number of specialist Working Groups, each with a broad topic area. The Working Groups have specific projects designed to achieve a set of particular objectives. This page will highlight the latest news and information from our projects. Participation is open to anyone who wants to contribute and if you would like to get involved, please
email 
email workinggroups@phuse.global.

Data Transparency Winter Event 2024

Image Removed

The PHUSE Data Transparency Winter Event will take place from 6–8 February 2024. Presenting at the Data Transparency Event offers you the chance to share your knowledge and experience with the wider data transparency community, allowing them to come together to discuss new ideas and spark innovation!

During this virtual event, presentations will be delivered across the three days in bitesize chunks from 15:00-17:30 (GMT). There will also be a panel discussion and Q&A session focused on the day's themes. Registration will openon 4 January!Real World Evidence Community Forum Series: RWD Quality Challenges – Different Perspectives

Image Removed

The Real World Evidence Working Group have been hosting a webinar series which will be continuing into 2024. The next upcoming webinar RWD Quality Challenges – Different Perspectives will be taking place on 18 January 2024 – 14:00–15:00 (GMT) 09:00–10:00 (EST). This webinar will be on the topic of Real World Data Quality challenges, looking at different perspectives from Dr Cheryl Grandinetti from the FDA and Kris Wenzel from MMS Holdings.

Register here now! 

Deliverables Calling for Feedback

Image Removed

Optimizing the Use of Data Standards project, Implementation of Estimands (ICH E9 (R1)) using Data Standards has produced a White Paper, which is now out for public review. This paper provides recommendations to facilitate the implementation of the estimands framework introduced by the ICH E9(R1) within the data flow, promoting alignment across the industry. These consist of best practices for using existing standards and extensions to data standards where applicable and are illustrated by examples, in scope where an impact assessment on Data Collection (CDASH), Data Tabulation (SDTM), Data Analysis (ADaM) and the Data Reviewers Guides (cSDRG and ADRG).

White Paper and Appendix (please note, there might be some visual issues with some of the tables, these will be corrected during the final editing stages for publication). Closing date: 17 January.

Please share any comments and thoughts via email, at workinggroups@phuse.global. Feedback will be shared with the project team to help them develop the final White Paper.

New Deliverables

Data Visualisation & Open Source Technology Working Group's project, Julia Initiative for High-Performance Computing has published their White Paper 'Julia for High-Performance Computing'This White Paper provides an overview of Julia’s features and benefits for high-performance computing, including its fast compilation, dynamic typing, multiple dispatch, and built-in support for parallelism. It also discusses current real-world use cases of Julia and potential case studies for high-performance computing, along with recommended readings and references for further exploration. Please head over to our PHUSE website to read!

The Cloud Adoption in the Life Sciences Industry project within the Emerging Trends and Technologies Working Group have published their white paper 'Cloud Framework, Pre-Amble', This paper explores adopting cloud-based solutions for GxP workloads, understanding why the essential characteristics of cloud services and solutions are important for determining the applicability of GxP requirements to specific Cloud Service Providers and/or cloud-based solution models.


Image Added


Open Source – Regulatory Acceptance of Open-Source Submissions

Registration for the Open Source Open Forum is open!

The Open Source Technology in Clinical Data Analysis (OSTCDA) project is hosting their fourth Open Forum: Regulatory Acceptance of Open-Source Submissions, they will be addressing the following questions:

  • Will the FDA accept data and analyses generated with solutions developed and available as open source?
  • Will other regulatory agencies accept data and analyses generated with solutions developed and available as open source?

Come and be a part of our next virtual Open Forum on 12 July at 15:00(BST) 10:00(EDT).

Status
colourBlue
titleRegister Here


Understanding the Complete Journey of RWD, from Data Source to Final Analysis 

Registration for the RWE Community Forum is open!

The Real World Evidence Working Group is hosting their third Community Forum of the year! This forum will looking at 'Understanding the Complete Journey of RWD, from Data Source to Final Analysis'. As an industry, we are continuously accumulating experiences in working with real-world data (RWD) sources that collectively yield benefits – from enhanced generalisability of findings to facilitating faster approval timelines. However, these efforts are not without their challenges.

Come and be a part of our next virtual Community Forum on 11 July at 14:00(BST) 9:00(EDT).

Status
colourBlue
titleRegister Here


Image Added


The Dataset-JSON as Alternative Transport Format for Regulatory Submissions project within the Optimizing the Use of Data Standards Working Group, has published a new white paper. A pilot was executed to test the feasibility of using Dataset-JSON as a transport format for study data submitted with regulatory applications. The goal was to demonstrate that Dataset-JSON can serve as a transport file for study data without loss of data and no significant impact to business operations.  

CDISC Dataset-JSON is a modern dataset format designed for data exchange. Many software applications already import and export JSON and in the longer term more significant benefits will emerge as the constraints imposed by XPT are removed. 

Overall, the findings were consistent across industry and the FDA supporting the use of Dataset-JSON as an alternative transport format for XPT v5.  There were several key findings from the pilot and the solutions to these will be implemented in Dataset-JSON v1.1 (due end of 2024). 

PHUSE and CDISC will continue to collaborate with the FDA/PMDA to discuss next steps for regulatory support. FDA/CDER/CBER testing strongly suggests that analytical tools used for regulatory review are updated to take advantage of the metadata and flexibility provided by the Dataset-JSON format. 


The SEND Industry Feedback Surveyproject within the Nonclinical Topics Working Group, has published the 2024 SEND Survey Results. The survey was presented at the PHUSE/FDA Computational Science Symposium (CSS) 2024 and covered topics such as Manual Edits, Implementing SEND, Harmonisation and Next Steps.


The Adverse Event Collection Recommendations project within the Safety Analytics Working Group, has published a new white paper The Adverse Event Collection Recommendations. This white paper provides recommendations for adverse event (AE) collection and associated instructions for Phase II to III clinical trials, building on standardisation efforts by Clinical Data Interchange Standards Consortium (CDISC) and PHUSE. The primary intent is to reduce the variation in AE collection and instructions to improve the site experience and the quality of the data.


The Quality and Reusability of Real World Data project within the Real World Evidence Working Group, has published two new Blogs! The 'Understanding the Data Quality Issues in Real-World Data Through Real-World Examples', blog takes a closer look at the experiences shared within the dedicated Working Group in exploring the types of data quality hurdles encountered when using Real-World Data (RWD).The 'Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products' blog explores the use of Real-World Evidence (RWE) as a powerful tool for informing regulatory decisions and advancing medical innovation.


The Educate the General Population on Data Privacy and Data Sharing project, within the Data Transparency Working Group has published video 2 of their series. The 'What Will I Receive and When Will I Receive It?The video covers topics such as the concept of consent to participate in a clinical trial, an overview of trial design and treatment procedures to develop a strong foundational understanding of clinical trials. To view the full series of videos created by this team, visit the PHUSE website


Image Added


Volunteer Opportunities

Image Removed

The Enhanced Risk-based Quality Management (RBQM) Approaches for First-in-Human and/or Small Clinical Trialsa new project within the Risk Based Quality ManagementWorking Group, is now calling for volunteers. This project aims to to discuss and focus on a robust strategy/process and best practices for:

  • Identifying critical items
  • Risk Based data review approaches
  • Risk Based Monitoring approach strategy (tSDV/tSDR)
  • Usage of analytical tools and methods for data review & central monitoring, including limitations on (statistical) methodologies
  • Identification of thresholds or equivalent on limited patient data
  • Targeted medical review
  • Strategy to adequately anticipate on highly dynamic data
  • Establish links with the other work streams on FIH/small studies focus

If you would like to volunteer or learn more about this project, email workinggroups@phuse.global. Closing date: 5 July

Multiple projects within Working Groups are open to join. PHUSE welcomes new members who can apply their knowledge to bring fresh ideas and contribute to the ongoing work of PHUSE projects. For more information, click here, read the Welcome Pack or email workinggroups@phuse.global

New Project Idea? 


Image Added


Working Groups Report: Includes project updates, recent and upcoming deliverables and future plans for each Working Group.

Monthly Mailings: The monthly newsletter. Here you will find a full update from each month of the year, easily accessible and divided into key areas of PHUSE.

PHUSE Blogs: Fancy a quick read? A blog is a perfect way to catch up on all things Working Groups. Get the lowdown on the latest events from across the globe and stay updated on industry topics brought to you by industry professionals. 


Image Added


Initiate and lead a new project under the PHUSE Working Groups umbrella. The new project must address problems of significant relevance to computational science related to drug, biological and device development and must meet all of the guidelines for projects within the collaboration, including the following mandatory requirements: 

  • The projects must address significant research issues relevant to Computational Science
  • The project must not attempt to address FDA policy issues
  • There must be at least one Project Lead personally involved in planning and carrying out the project

New projects can be submitted anytime during the year, click here to submit

PHUSE Communications 

Working Groups Report: Includes project updates, recent and upcoming deliverables and the future plans for each Working Group.

Monthly Mailings: The monthly newsletter. Here you will find a full update from each month of the year, easily accessible and divided into key areas of PHUSE.

PHUSE Blogs: Fancy a quick read? A blog is the perfect way to catch up on all things Working Groups. Get the lowdown on the latest events from across the globe and stay updated on industry topics brought to you by industry professionals